Regeneron Pharmaceuticals (REGN) EBIT Growth (3y) (2012 - 2026)
Regeneron Pharmaceuticals (REGN) EBIT Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -1,580.97% |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 32.96% |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -29.67% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 16.35% |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -50.81% |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 13.47% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | -12.10% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.10% |
| Dec 31, 2025 | -8.45% |
| Sep 30, 2025 | -5.68% |
| Jun 30, 2025 | -0.92% |
| Mar 31, 2025 | -22.24% |
| Dec 31, 2024 | -27.88% |
| Sep 30, 2024 | -13.89% |
| Jun 30, 2024 | -31.63% |
| Mar 31, 2024 | -12.27% |
| Dec 31, 2023 | -5.88% |
| Sep 30, 2023 | 1.80% |
| Jun 30, 2023 | 15.69% |
| Mar 31, 2023 | 10.58% |
| Dec 31, 2022 | 19.28% |
| Sep 30, 2022 | 18.33% |
| Jun 30, 2022 | 52.07% |
| Mar 31, 2022 | 37.89% |
| Dec 31, 2021 | 54.33% |
| Sep 30, 2021 | 43.36% |
| Jun 30, 2021 | 75.22% |